Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

FDA approves ORALAIR sublingual allergy immunotherapy tablet

GREER Laboratories, Inc., a leading developer and provider of allergy immunotherapy products and services, today announced that the U.S. Food and Drug Administration has approved ORALAIR (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass Mixed Pollens Allergen Extract) sublingual allergy immunotherapy tablet.

2 Apr 2014

Nearly 4 million infants die from vaccine-preventable diseases worldwide each year

Nearly 4 million children under 5 die from vaccine-preventable diseases worldwide each year, and two University of Michigan doctoral ecology students are working to change that.

2 Apr 2014

EPFL scientists develop computer tool to identify mutations that make influenza resistant to Tamiflu

Tamiflu is one of the few available treatments for those who come down with the flu. But the virus quickly develops resistance; multiplying at a rate of several generations a day, these tiny pathogens rapidly accumulate genetic mutations. Because of this, they have a good chance of developing counterattacks to the antiviral. How can these infinitesimal variations be identified within the immensity of the virus' genetic code? EPFL researchers have created a computer tool that can shed light on the flu virus' formidable adaptability.

1 Apr 2014

S. pneumoniae is commonest cause of paediatric CAP

Streptococcus pneumoniae is the predominant cause of community-acquired pneumonia among children in Belgium, with non-vaccine serotypes accounting for the majority of cases, a Belgian study shows.

31 Mar 2014

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Amgen (NASDAQ: AMGN) today announced new detailed data from three Phase 3 studies that showed treatment with its novel investigational cholesterol-lowering medication, evolocumab (AMG 145), resulted in a statistically significant reduction of 55-66 percent in low-density lipoprotein cholesterol (LDL-C) compared to placebo in patients with high cholesterol.

31 Mar 2014

Clinigen Group announces acquisition of SAVENE oncology support therapy from SpePharm

Clinigen Group plc ('Clinigen' or the 'Group') the specialty global pharmaceutical company today announces the acquisition of SAVENE® (dexrazoxane) from SpePharm AG, a majority owned affiliate of Norgine B.V. The Financial terms of the acquisition are not being disclosed.

From Clinigen Group 31 Mar 2014

Consumer Healthcare Products Association thanks Washington State gov for signing SSHB 2163 bill

The Consumer Healthcare Products Association thanks Washington State Governor Jay Inslee for signing SSHB 2163 and Rep. Paul Harris for the initial introduction of the legislation.

31 Mar 2014

Study reports benefits of implementing bronchiolitis guidelines at Children's Medical Center Dallas

Bronchiolitis, the number-one cause of infant hospitalizations nationally, was the focus of a multidisciplinary effort by physicians and clinicians at Children's Medical Center Dallas to establish and implement clinical practice guidelines (CPGs) aimed at streamlining care and reducing unnecessary tests and therapies.

29 Mar 2014

ADMA Biologics reports consolidated net loss of $15.5M in 2013

ADMA Biologics, Inc., a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, today announced its financial results for the year ended December 31, 2013 and provided recent company developments as well as anticipated milestones for 2014.

28 Mar 2014

Early life chronic stress may cause anxiety in adulthood, says study

In recent years, behavioral neuroscientists have debated the meaning and significance of a plethora of independently conducted experiments seeking to establish the impact of chronic, early-life stress upon behavior - both at the time that stress is experienced, and upon the same individuals later in life, during adulthood.

28 Mar 2014

Prevalence of autism among 8-year-olds continues to rise in New Jersey

According to a new report from the Centers for Disease Control and Prevention, the estimated prevalence of autism among 8-year-olds in New Jersey rose in the latest reporting year, 2010, to nearly 22 children per thousand, or approximately one child in 45.

28 Mar 2014

TSRI scientists receive $2.3M to study viruses that cause tropical diseases

The outbreak of dengue fever that infected some 20 people in Florida's Martin County late last year unnerved many who feared the tropical disease had once again established a foothold in Florida. The last outbreaks occurred in 2009 and 2010 in Key West—before that, the disease hadn't struck Florida in more than 70 years.

28 Mar 2014

Hospital infection rates down, but patients still dying of preventable causes

Hospitals and nursing homes have been trying to cut the facility-acquired infection rates, which has worked better for some conditions than others.

28 Mar 2014

Novel storage device transports vaccines to remote parts of the world

Getting life-saving vaccines to the most remote parts of the world is no easy feat. Biopharmaceuticals are highly sensitive to heat and cold and can perish if their temperature shifts a few degrees.

27 Mar 2014

A fast, non-invasive method to genotype late-onset Alzheimer's disease

The apolipoprotein E gene ε4 allele is considered a negative factor for neural regeneration in late-onset Alzheimer's disease cases.

27 Mar 2014

Low dose injections of artificial properdin provides protection against septic diseases in mice

Breakthrough MRC-funded study from University of Leicester shows low dose injections of artificial properdin provides substantial protection against septic diseases in mice

26 Mar 2014

Inovio Pharmaceuticals receives three industry awards at World Vaccine Congress

Inovio Pharmaceuticals, Inc. today announced that it was recognized with three industry awards at the World Vaccine Congress, which is being held this week in Washington, D.C. The Vaccine Industry Excellence (ViE) Awards recognize outstanding vaccine advancements and achievements of therapeutic and preventive vaccine developers across the global industry as judged by a panel of global biotech industry stakeholders.

26 Mar 2014

ASU scientist selected as 2014 recipient of Lifetime Achievement Award

Roy Curtiss III, a scientist at the Biodesign Institute at Arizona State University, has been selected as the 2014 recipient of the Lifetime Achievement Award from the American Society for Microbiology.

26 Mar 2014

Researchers develop mathematical model that provides insights about molecular mechanisms behind virus assembly

Mathematicians at the University of York have joined forces with experimentalists at the University of Leeds to take an important step in discovering how viruses make new copies of themselves during an infection.

25 Mar 2014

Study suggests that self-administration of influenza vaccine may be feasible with microneedle patch

There are many reasons some people may not get a flu shot, but would they be more likely to do so if there was a simple device that could be mailed directly to them, was easy enough to use by themselves, and provided at least the same level of protection as a traditional flu shot without the pain of a needle jab? A recent NIBIB-funded study, published online February 2014 in the journal Vaccine, suggests the answer is yes.

25 Mar 2014

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

FDA approves ORALAIR sublingual allergy immunotherapy tablet

Nearly 4 million infants die from vaccine-preventable diseases worldwide each year

EPFL scientists develop computer tool to identify mutations that make influenza resistant to Tamiflu

S. pneumoniae is commonest cause of paediatric CAP

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Clinigen Group announces acquisition of SAVENE oncology support therapy from SpePharm

Consumer Healthcare Products Association thanks Washington State gov for signing SSHB 2163 bill

Study reports benefits of implementing bronchiolitis guidelines at Children's Medical Center Dallas

ADMA Biologics reports consolidated net loss of $15.5M in 2013

Early life chronic stress may cause anxiety in adulthood, says study

Prevalence of autism among 8-year-olds continues to rise in New Jersey

TSRI scientists receive $2.3M to study viruses that cause tropical diseases

Hospital infection rates down, but patients still dying of preventable causes

Novel storage device transports vaccines to remote parts of the world

A fast, non-invasive method to genotype late-onset Alzheimer's disease

Low dose injections of artificial properdin provides protection against septic diseases in mice

Inovio Pharmaceuticals receives three industry awards at World Vaccine Congress

ASU scientist selected as 2014 recipient of Lifetime Achievement Award

Researchers develop mathematical model that provides insights about molecular mechanisms behind virus assembly

Study suggests that self-administration of influenza vaccine may be feasible with microneedle patch

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in